{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:23:33Z","timestamp":1795159413092,"version":"4.10.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":5760,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1111\/j.1538-7836.2007.02372.x","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T08:33:46Z","timestamp":1172046826000},"page":"475-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study"],"prefix":"10.1016","volume":"5","author":[{"given":"P.E.","family":"MORANGE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"BLANKENBERG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"ALESSI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"BICKEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"RUPPRECHT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"SCHNABEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"LUBOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"M\u00dcNZEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"PEETZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"NICAUD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"JUHAN-VAGUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"TIRET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2013 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0015","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0020","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.99.14.1780","article-title":"Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions","volume":"99","author":"Badimon","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-134-3-200102060-00014","article-title":"Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences","volume":"134","author":"Rauch","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0030","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0035","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood\u2010borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0040","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0038-1650365","article-title":"Detection of circulating tissue factor and factor VII in a normal population","volume":"75","author":"Albrecht","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0045","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9149(96)00288-3","article-title":"Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction","volume":"78","author":"Soejima","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9149(97)00801-1","article-title":"Comparison of plasma tissue factor levels in unstable and stable angina pectoris","volume":"81","author":"Misumi","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0055","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.99.22.2908","article-title":"Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina","volume":"99","author":"Soejima","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0060","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1021\/bi00485a001","article-title":"Regulation of coagulation by a multivalent Kunitz\u2010type inhibitor","volume":"29","author":"Broze","year":"1990","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0070","first-page":"154","article-title":"Tissue factor pathway inhibitor (TFPI): an update","volume":"26","author":"Sandset","year":"1996","journal-title":"Haemostasis"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.ATV.16.6.802","article-title":"Measurement of the free form of TFPI antigen in hyperlipidemia: relationship between free and endothelial cell\u2010associated forms of TFPI","volume":"16","author":"Kokawa","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.ATV.20.1.251","article-title":"Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A\u2010II","volume":"20","author":"Kawaguchi","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1538-7836.2005.01237.x","article-title":"A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)","volume":"3","author":"Dahm","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/01.CIR.0000120705.55512.EC","article-title":"Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study","volume":"109","author":"Morange","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.ATV.0000013904.40673.CC","article-title":"Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects","volume":"22","author":"Kato","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/hc2601.091703","article-title":"Impact of viral and bacterial infectious burden on long\u2010term prognosis in patients with coronary artery disease","volume":"104","author":"Rupprecht","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0105","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.0000050621.67499.7D","article-title":"Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity","volume":"107","author":"Sambola","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ Res"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.CIR.91.3.619","article-title":"Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes","volume":"91","author":"Annex","year":"1995","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0120","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/01.ATV.17.10.2232","article-title":"Tissue factor expression on macrophages in coronary plaques in patients with unstable angina","volume":"17","author":"Kaikita","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0125","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1161\/01.ATV.0000191637.48129.9b","article-title":"Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes","volume":"25","author":"Malarstig","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.CIR.98.11.1051","article-title":"Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity","volume":"98","author":"Caplice","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1989.tb07721.x","article-title":"Factor VII and extrinsic pathway inhibitor in acute coronary disease","volume":"72","author":"Sandset","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2004-03-1106","article-title":"Circulating endothelial cells, von Willebrand factor, interleukin\u20106, and prognosis in patients with acute coronary syndromes","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0145","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0150","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V78.2.394.394","article-title":"Purification and properties of heparin\u2010releasable lipoprotein\u2010associated coagulation inhibitor","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2007.02372.x_bb0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-2001-17952","article-title":"Molecular weight\u2010dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma","volume":"27","author":"Alban","year":"2001","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02372.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622101327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622101327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02372.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:41:35Z","timestamp":1761532895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622101327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1538783622101327"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02372.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02372.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}